This project aims to develop a novel class of drugs with the potential to overcome the stability problems previously associated with protein-based drugs. We will develop novel molecules for the treatment of cancer and cardiovascular disease. This project has the potential to lead to major economic and social benefits to Australia via royalty returns from drug sales and reduced costs for health care for patients with these diseases.
Building Tissue Engineered Flaps For Surgical Reconstruction
Funder
National Health and Medical Research Council
Funding Amount
$548,453.00
Summary
As a result of serious trauma, burns or cancer surgery, large areas of new skin may be required. Of the three major skin layers - epidermal and dermal replacements are available clinically, but the third layer - the underlying fat tissue layer is yet to be developed. This project has devised a novel product to rapidly recreate the skin fat layer and additionally rapidly grow new blood vessels in these layers which will enable excellent skin coverage in all forms of major skin loss.